Based on the results of this study, the following findings were reported: Homozygosity for HFE H63D polymorphism may be a genetic modifier of disease manifestation and the risk of CRC was significantly higher for H63D homozygotes in comparison to the wild-type homozygotes and heterozygotes. The gene discussed is HFE; the disease is colorectal carcinoma.